KLX 170 (Fenofibrate 54 mg)
Pill imprint KLX 170 has been identified as Fenofibrate 54 mg.
Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type v, elevated chylomicrons vldl; hyperlipoproteinemia; hyperlipoproteinemia type iib, elevated ldl vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 54 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for KLX 170 (Fenofibrate 54 mg)
- Imprint:
-
KLX
170 - Strength:
- 54 mg
- Color:
- Yellow
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Karalex Pharma
- National Drug Code (NDC):
- 42043-0170
- Inactive Ingredients:
- betadex
silicon dioxide
calcium phosphate dihydrate dibasic
docusate sodium
sodium benzoate
hypromellose
magnesium stearate
microcrystalline cellulose
polyethylene glycol
polysorbate 80
sodium starch glycolate type A potato
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
More resources
Fenofibrate is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
